All lobbying filings
Continental Strategy, LLC
Continental Strategy, LLC filed a Q1 report for Vivex Biologics on April 18, 2026, reporting $120,000 in lobbying income.
Lobbying for Vivex Biologics · regenerative medicine company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 18, 2026
Income
$120,000
What the client paid this registrant for the period.
Client based in
Florida
Lobbyists on this filing
2
-
TIMOTHY COSTAPreviously held: Former Chief of Staff to Dan Meuser
-
LUKE NICKLESSPreviously held: Former Senior Policy Advisor, Appropriations, House Committee on the Budget
Government bodies contacted
2
Lobbying activity
2
regenerative and innovative medical solutions
regenerative and innovative medical solutions